|
1
|
Fujimura N: Pathology and pathophysiology
of pneumoconiosis. Curr Opin Pulm Med. 6:140–144. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mossman BT and Churg A: Mechanisms in the
pathogenesis of asbestosis and silicosis. Am J Respir Crit Care
Med. 157:1666–1680. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Seaman DM, Meyer CA and Kanne JP:
Occupational and environmental lung disease. Clin Chest Med.
36:249–268. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cassel SL, Eisenbarth SC, Iyer SS, Sadler
JJ, Colegio OR, Tephly LA, Carter AB, Rothman PB, Flavell RA and
Sutterwala FS: The Nalp3 inflammasome is essential for the
development of silicosis. Proc Natl Acad Sci USA. 105:9035–9040.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dostert C, Pétrilli V, Van Bruggen R,
Steele C, Mossman BT and Tschopp J: Innate immune activation
through Nalp3 inflammasome sensing of asbestos and silica. Science.
320:674–677. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hornung V, Bauernfeind F, Halle A, Samstad
EO, Kono H, Rock KL, Fitzgerald KA and Latz E: Silica crystals and
aluminum salts activate the NALP3 inflammasome through phagosomal
destabilization. Nat Immunol. 9:847–856. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nishimura Y, Miura Y, Maeda M, Kumagai N,
Murakami S, Hayashi H, Fukuoka K, Nakano T and Otsuki T: Impairment
in cytotoxicity and expression of NK cell- activating receptors on
human NK cells following exposure to asbestos fibers. Int J
Immunopathol Pharmacol. 22:579–590. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nishimura Y, Maeda M, Kumagai N, Hayashi
H, Miura Y and Otsuki T: Decrease in phosphorylation of ERK
following decreased expression of NK cell-activating receptors in
human NK cell line exposed to asbestos. Int J Immunopathol
Pharmacol. 22:879–888. 2009. View Article : Google Scholar
|
|
9
|
Nishimura Y, Maeda M, Kumagai-Takei N, Lee
S, Matsuzaki H, Wada Y, Nishiike-Wada T, Iguchi H and Otsuki T:
Altered functions of alveolar macrophages and NK cells involved in
asbestos-related diseases. Environ Health Prev Med. 18:198–204.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kumagai-Takei N, Nishimura Y, Maeda M,
Hayashi H, Matsuzaki H, Lee S, Hiratsuka J and Otsuki T: Effect of
asbestos exposure on differentiation of cytotoxic T lymphocytes in
mixed lymphocyte reaction of human peripheral blood mononuclear
cells. Am J Respir Cell Mol Biol. 49:28–36. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kumagai-Takei N, Nishimura Y, Maeda M,
Hayashi H, Matsuzaki H, Lee S, Kishimoto T, Fukuoka K, Nakano T and
Otsuki T: Functional properties of CD8(+) lymphocytes in patients
with pleural plaque and malignant mesothelioma. J Immunol Res.
2014:6701402014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kumagai-Takei N, Nishimura Y, Matsuzaki H,
Maeda M, Lee S, Yoshitome K and Otsuki T: Effects of asbestos
fibers on human cytotoxic T cells. Biological Effects of Fibrous
and Particulate Substances (Series Title: Current Topics in
Environmental Health and Preventive Medicine). Otsuki T, Holian A
and Yoshioka Y: Springer-Japan; pp. 211–221. 2015
|
|
13
|
Kumagai-Takei N, Nishimura Y, Matsuzaki H,
Lee S, Yoshitome K, Hayashi H and Otsuki T: The suppressed
induction of human mature cytotoxic T lymphocytes caused by
asbestos is not due to Interleukin-2 insufficiency. J Immunol Res.
2016:74848722016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hyodoh F, Takata-Tomokuni A, Miura Y,
Sakaguchi H, Hatayama T, Hatada S, Katsuyama H, Matsuo Y and Otsuki
T: Inhibitory effects of anti-oxidants on apoptosis of a human
poly-clonal T-cell line, MT-2, induced by an asbestos,
chrysotile-A. Scand J Immunol. 61:442–448. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Miura Y, Nishimura Y, Katsuyama H, Maeda
M, Hayashi H, Dong M, Hyodoh F, Tomita M, Matsuo Y, Uesaka A, et
al: Involvement of IL-10 and Bcl-2 in resistance against an
asbestos-induced apoptosis of T cells. Apoptosis. 11:1825–1835.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Maeda M, Chen Y, Kumagai-Takei N, Hayashi
H, Matsuzaki H, Lee S, Hiratsuka J, Nishimura Y, Kimura Y and
Otsuki T: Alteration of cytoskeletal molecules in a human T cell
line caused by continuous exposure to chrysotile asbestos.
Immunobiology. 218:1184–1191. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Maeda M, Nishimura Y, Hayashi H, Kumagai
N, Chen Y, Murakami S, Miura Y, Hiratsuka J, Kishimoto T and Otsuki
T: Reduction of CXC chemokine receptor 3 in an in vitro model of
continuous exposure to asbestos in a human T-cell line, MT-2. Am J
Respir Cell Mol Biol. 45:470–479. 2011. View Article : Google Scholar
|
|
18
|
Maeda M, Nishimura Y, Hayashi H, Kumagai
N, Chen Y, Murakami S, Miura Y, Hiratsuka J, Kishimoto T and Otsuki
T: Decreased CXCR3 expression in CD4+ T cells exposed to
asbestos or derived from asbestos-exposed patients. Am J Respir
Cell Mol Biol. 45:795–803. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kumagai-Takei N, Maeda M, Chen Y,
Matsuzaki H, Lee S, Nishimura Y, Hiratsuka J and Otsuki T: Asbestos
induces reduction of tumor immunity. Clin Dev Immunol.
2011:4814392011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Matsuzaki H, Maeda M, Lee S, Nishimura Y,
Kumagai-Takei N, Hayashi H, Yamamoto S, Hatayama T, Kojima Y,
Tabata R, et al: Asbestos-induced cellular and molecular alteration
of immunocompetent cells and their relationship with chronic
inflammation and carcinogenesis. J Biomed Biotechnol.
2012:4926082012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Otsuki T, Matsuzaki H, Lee S,
Kumagai-Takei N, Yamamoto S, Hatayama T, Yoshitome K and Nishimura
Y: Environmental factors and human health: Fibrous and particulate
substance-induced immunological disorders and construction of a
health-promoting living environment. Environ Health Prev Med.
21:71–81. 2016. View Article : Google Scholar :
|
|
22
|
Craighead JE: Nonthoracic cancers possibly
resulting from asbestos exposure. Asbestos and its Diseases.
Craighead JE and Gibbs AR: Oxford University Press; New York: pp.
230–252. 2008, View Article : Google Scholar
|
|
23
|
Freidman GK: Malignant diseases attributed
to asbestos exposure. Asbestos. Risk assessment, epidemiology, and
health effects. Dodson RF and Hammar SP: CRC Press; Boca Raton: pp.
561–592. 2011, View Article : Google Scholar
|
|
24
|
Alizadeh D, Katsanis E and Larmonier N:
The multifaceted role of Th17 lymphocytes and their associated
cytokines in cancer. Clin Dev Immunol. 2013:9578782013. View Article : Google Scholar
|
|
25
|
Bailey SR, Nelson MH, Himes RA, Li Z,
Mehrotra S and Paulos CM: Th17 cells in cancer: The ultimate
identity crisis. Front Immunol. 5:2762014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lakshmi Narendra B, Eshvendar Reddy K,
Shantikumar S and Ramakrishna S: Immune system: A double-edged
sword in cancer. Inflamm Res. 62:823–834. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zou W and Restifo NP: T(H)17 cells in
tumour immunity and immunotherapy. Nat Rev Immunol. 10:248–256.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ferro A, Zebedeo CN, Davis C, Ng KW and
Pfau JC: Amphibole, but not chrysotile, asbestos induces
anti-nuclear autoantibodies and IL-17 in C57BL/6 mice. J
Immunotoxicol. 11:283–290. 2014. View Article : Google Scholar
|
|
29
|
Serve KM, Black B, Szeinuk J and Pfau JC:
Asbestos-associated mesothelial cell autoantibodies promote
collagen deposition in vitro. Inhal Toxicol. 25:774–784. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pfau JC, Serve KM and Noonan CW:
Autoimmunity and asbestos exposure. Autoimmune Dis.
2014:7820452014.PubMed/NCBI
|
|
31
|
Zebedeo CN, Davis C, Peña C, Ng KW and
Pfau JC: Erionite induces production of autoantibodies and IL-17 in
C57BL/6 mice. Toxicol Appl Pharmacol. 275:257–264. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Maeda M, Yamamoto S, Chen Y, Kumagai-Takei
N, Hayashi H, Matsuzaki H, Lee S, Hatayama T, Miyahara N, Katoh M,
et al: Resistance to asbestos-induced apoptosis with continuous
exposure to crocidolite on a human T cell. Sci Total Environ.
429:174–182. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huang SX, Jaurand MC, Kamp DW, Whysner J
and Hei TK: Role of mutagenicity in asbestos fiber-induced
carcinogenicity and other diseases. J Toxicol Environ Health B Crit
Rev. 14:179–245. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mossman BT and Craighead JE: Mechanisms of
asbestos carcinogenesis. Environ Res. 25:269–280. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Moyer VD, Cistulli CA, Vaslet CA and Kane
AB: Oxygen radicals and asbestos carcinogenesis. Environ Health
Perspect. 102(Suppl 10): 131–136. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Toyokuni S: Iron overload as a major
targetable pathogenesis of asbestos-induced mesothelial
carcinogenesis. Redox Rep. 19:1–7. 2014. View Article : Google Scholar
|
|
37
|
LaFave LM, Béguelin W, Koche R, Teater M,
Spitzer B, Chramiec A, Papalexi E, Keller MD, Hricik T,
Konstantinoff K, et al: Loss of BAP1 function leads to
EZH2-dependent transformation. Nat Med. 21:1344–1349. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sekido Y: Molecular pathogenesis of
malignant mesothelioma. Carcinogenesis. 34:1413–1419. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Singhi AD, Krasinskas AM, Choudry HA,
Bartlett DL, Pingpank JF, Zeh HJ, Luvison A, Fuhrer K, Bahary N,
Seethala RR, et al: The prognostic significance of BAP1, NF2, and
CDKN2A in malignant peritoneal mesothelioma. Mod Pathol. 29:14–24.
2016. View Article : Google Scholar
|
|
40
|
Maeda M, Yamamoto S, Hatayama T, Matsuzaki
H, Lee S, Kumagai-Takei N, Yoshitome K, Nishimura Y, Kimura Y and
Otsuki T: T cell alteration caused by exposure to asbestos.
Biological Effects of Fibrous and Particulate Substances, (Series
Title: Current Topics in Environmental Health and Preventive
Medicine). Otsuki T, Holian A and Yoshioka Y: Springer; Tokyo: pp.
195–210. 2015
|
|
41
|
O'Connor RA, Taams LS and Anderton SM:
Translational mini-review series on Th17 cells: CD4 T helper cells:
functional plasticity and differential sensitivity to regulatory T
cell-mediated regulation. Clin Exp Immunol. 159:137–147. 2010.
View Article : Google Scholar :
|
|
42
|
Olson NC, Sallam R, Doyle MF, Tracy RP and
Huber SA: T helper cell polarization in healthy people:
Implications for cardiovascular disease. J Cardiovasc Transl Res.
6:772–786. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ying C, Maeda M, Nishimura Y,
Kumagai-Takei N, Hayashi H, Matsuzaki H, Lee S, Yoshitome K,
Yamamoto S, Hatayama T, et al: Enhancement of regulatory T
cell-like suppressive function in MT-2 by long-term and low-dose
exposure to asbestos. Toxicology. 338:86–94. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lee S, Matsuzaki H, Maeda M, Yamamoto S,
Kumagai-Takei N, Hatayama T, Ikeda M, Yoshitome K, Nishimura Y and
Otsuki T: Accelerated cell cycle progression of human regulatory T
cell-like cell line caused by continuous exposure to asbestos
fibers. Int J Oncol. 50:66–74. 2017.
|
|
45
|
Tsujioka T, Miura Y, Otsuki T, Nishimura
Y, Hyodoh F, Wada H and Sugihara T: The mechanisms of vitamin
K2-induced apoptosis of myeloma cells. Haematologica. 91:613–619.
2006.PubMed/NCBI
|
|
46
|
Otsuki T, Yata K, Takata-Tomokuni A,
Hyodoh F, Miura Y, Sakaguchi H, Hatayama T, Hatada S, Tsujioka T,
Sato Y, et al: Expression of protein gene product 9.5
(PGP9.5)/ubiquitin-C-terminal hydrolase 1 (UCHL-1) in human myeloma
cells. Br J Haematol. 127:292–298. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Otsuki T, Yamada O, Kurebayashi J, Moriya
T, Sakaguchi H, Kunisue H, Yata K, Uno M, Yawata Y and Ueki A:
Estrogen receptors in human myeloma cells. Cancer Res.
60:1434–1441. 2000.PubMed/NCBI
|
